The effects of rituximab treatment during pregnancy on a neonate

Haematologica

Volumn 91, Issue 10, 2006, Pages 1426-1427

  Friedrichs, Birte ^a   Tiemann, Markus ^b   Salwender, Hans ^c   Verpoort, Karl ^a   Wenger, Michael K ^d   Schmitz, Norbert ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b Institute for Hematopathology   (Germany)

^c ASKLEPIOS KLINIK ALTONA   (Germany)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

B cell development; Pregnancy; Rituximab

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER REGRESSION; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; PREGNANCY; VACCINATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; PREDNISONE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VINCRISTINE;

EID: 33749999729     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Armitage JO, Feagler JR, Skoog DP. Burkitts Lymphoma during pregnancy with bilateral breast involvement. JAMA 1977;237:151.
2. Antic N, Colovic M, Cemerikic V, Jankovic S, Petrovic M, Jankovi G. Disseminated Burkitt's-like lymphoma during pregnancy. Med Oncol 2000;17:233-6.
3. Barnes MN, Barrett JC, Kimberlin DF, Kilgore LC. Burkitt lymphoma in pregnancy. Obstet Gynecol 1998;92:675-8.
4. Aviles A, Diaz-Maqueo, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991;36:243-8.
5. Kimby E, Sverrisdotir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004;72:292-5.
6. Herold M, Schnohr S, Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 2001;19:3439.
7. Iacona I, Lazzarino M, Antonietta M et al. Rituximab (IDEC-C2B8) validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study. Ther Drug Monit 2000;22:295-301.
8. Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod 1999;4:81-9.
9. Cumano A, Kee BL, Ramsden DA, Marshall A, Paige CJ, Wu GE. Development of B-lymphocytes from lymphoid committed and uncommitted progenitors. Immunol Rev 1994;137:5-33.
10. Hardy RR, Hayakawa K. B-lineage Differentiation stages resolved by multiparameter flow cytometry. Ann N Y Acad Sci 1995;764:19-24.